Congenital short QT syndrome

Indian Pacing and Electrophysiology Journal

Volumn 10, Issue 2, 2010, Pages 86-95

  Crotti, Lia ^a,b   Taravelli, Erika ^a,b   Girardengo, Giulia ^a,b   Schwartz, Peter J ^a,b,c,d,e  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Channelopathies; ICD; Short QT syndrome; Sudden cardiac death

Indexed keywords

AMIODARONE; DISOPYRAMIDE; FLECAINIDE; IBUTILIDE; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNJ2; POTASSIUM CHANNEL KCNQ1; PROPAFENONE; QUINIDINE; SOTALOL; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; ELECTROCARDIOGRAPHY; FAMILY HISTORY; GENE; GENE MUTATION; HEART ATRIUM FIBRILLATION; HEART FUNCTION TEST; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTATION; REVIEW; SHORT QT INTERVAL; SHORT QT SYNDROME; SUDDEN DEATH; T WAVE;

EID: 77649113146     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Schwartz PJ, Crotti L. Long and short QT syndrome. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology: from cell to bedside. 5th ed. Philadelphia, Pa: Elsevier/Saunders: 2009: 731-744.
2. Gussak I, Brugada P, Brugada J et al. Idiopathic short QT interval: a new clinical syndrome? Cardiology. 2000: 94: 99-102.
3. Algra A, Tijssen JG, Roelandt JR et al. QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. Br Heart J. 1993: 70: 43-8.
4. Gaita F, Giustetto C, Bianchi F et al. Short QT Syndrome: a familial cause of sudden death. Circulation. 2003: 108: 965-70.
5. Brugada R, Hong K, Dumaine R et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004: 109: 30-5.
6. Cordeiro JM, Brugada R, Wu YS et al. Modulation of Ikr inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome. Cardiovascular Research 2005: 67: 498-509.
7. Bellocq C, van Ginneken AC, Bezzina CR et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 2004: 109: 2394-7.
8. Hong K, Piper DR, Diaz-Valdecantos A et al. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res. 2005: 68: 433-40.
9. Priori SG, Pandit SV, Rivolta I et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res. 2005: 96: 800-7.
10. Antzelevitch C, Pollevick GD, Cordeiro JM et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007: 115: 442-9.
11. Giustetto C, Di Monte F, Wolpert C et al. Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J. 2006: 27: 2440-7.
12. M Arnestad, L. Crotti, T. O. Rognum, et al. Prevalence of Long-QT syndrome gene variants in sudden infant death syndrome, Circulation, 2007: 115: 361-7.
13. Rhodes TE, Abraham RL, Welch RC, et al. Cardiac potassium channel dysfunction in sudden infant death syndrome. J Mol Cell Cardiol. 2008: 44: 571-81.
14. Viskin S, Zeltser D, Ish-Shalom M et al. Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm 2004: 1: 587-591.
15. Gallagher MM, Magliano G, Yap YG et al. Distribution and Prognostic Significance of QT Intervals in the Lowest Half Centile in 12,012 Apparently Healthy Persons. Am J Cardiol. 2006: 98: 933-935.
16. Anttonen O, Junttila MJ, Rissanen H et al. Prevalence and Prognostic Significance of Short QT Interval in a Middle-Aged Finish Population. Circulation 2007: 116: 714-720.
17. Extramiana F, Antzelevitch C. Amplified transmural dispersion of repolarization as the basis for arrhytmogenesis in a canine ventricular-wedge model of short-QT syndrome. Circulation 2004: 110: 3661-3666.
18. Anttonen O, Vaananen H, Junttila J et al. Electrocardiographic Transmural Dispersion of Repolarization in Patients with Inherited Short QT Sindrome. Ann Noninvasive Electrocardiol. 2008: 13: 295-300.
19. Borggrefe M, Wolpert C, Antzelevitch C et al. Short QT syndrome Genotype-phenotype correlations. Journal of Electrocardiology 2005: 38: 75-80.
20. Wolpert C, Schimpf R, Giustetto C et al. Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol. 2005: 16: 54-58.
21. Schimpf R, Wolpert C, Gaita F et al. Short QT syndrome review. Cardiovascular Research 2005: 67: 357-366.
22. Gaita F, Giustetto C, Bianchi F et al. Short QT sindrome: Pharmacological treatment. J Am Coll Cardiol. 2004: 43: 1494-9.
23. Hong K, Bjerregaard P, Gussak I, et al. Short QT syndrome et atrial fibrillation caused by mutation in KCNH2. J Cardiovas Electrophysiol. 2005: 16: 394-396.
24. Lu LX, Zhou W, Zhang X et al. Short QT Syndrome: a case report and review of literature. Resuscitation 2006: 71: 115-121.
25. McPate MJ, Duncan RS, Witchel HJ et al. Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome. J Mol Cell Cardiol. 2006; 41: 563.
26. Schimpf R, Veltmann C, Giustetto C et al. In vivo Effects of Mutant HERG K+ Channel Inhibition by Disopyramide in Patients with a Short QT-1 Syndrome: A Pilot Study. J Cardiovasc Electrophysiol. 2007: 18: 1157-60.
27. Schimpf R, Wolpert C, Bianchi F et al. Congenital Short QT Syndrome and Implantable Cardioverter Defibrillator Treatment: Inherent Risk for Inappropriate Shock Delivery. J Cardiovasc Electrophysiol 2003: 14: 1273-1277.
28. Boriani G, Biffi M, Valzania C et al. Short QT Syndromeand arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children. European Heart Journal 2006: 27: 2382-2384.
29. Thomas SA, Friedmann E, Kao CW et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care 2006: 15: 389-398.
30. Lunati et al. Linee Guida AIAC 2006 all'impianto di pacemaker, dispositivi per la resincronizzazione cardiaca (CRT) e defibrillatori automatici impiantabili (ICD). GIAC 2005: 8: 1-58.